跳至主要内容
临床试验/JPRN-UMIN000023827
JPRN-UMIN000023827招募中未知

Evaluation of the effectiveness of the orexin receptor antagonist (Suvorexant) for type 2 diabetes with untreated sleep disorder. - SUCCESS(Suvorexant clinical study on diabetes with sleep disorder)

Toho University School of Medicine0 个研究点目标入组 40 人开始时间: 2016年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Type 1 diabetes mellitus patients or secondary diabetic mellitus (2)Patients taking a sleeping drugs or antipsychotic within one year. (3) Patients who had myocardial infarction within 3 months, or obvious heart failure case (4) Patients with diabetic ketoacidosis or diabetic coma or risk of diabetic coma (5) Patients with severe liver disease (6) Patients with severe renal disease (7) Patients with severe pancreas disease (8) Patients with severe diabetic neuropathy (9) Patients having a proliferative retinopathy (10) Patients with a serious infectious disease or a serious injury (11) Excessive common custom drinker (12) A pregnant woman or the woman who may be pregnant (13) In addition, the patients who will be judged inappropriate by an attendant physician

研究者

发起方
Toho University School of Medicine

相似试验